Summary Seventy-five nude mice received subcutaneous inoculation with 1 x 107 cells of the human colonic cancer cell lines COLO-320 or HT-29. Tumour growth was assessed over 4 weeks in animals given one of three iso-caloric diets: standard diet, high saturated fat (20% coconut) diet and high n-3 fat (20% Maxepa fish oil) diet. The n-3 diet produced significant tumour growth reduction compared to the other diets for COLO-320 at 3 to 4 weeks (P<0.05 at least) and similarly for HT-29 at 4 weeks (P<0.05). Significant incorporation of n-3 fatty acids occurred in red cell membranes, adipose tissue and both neutral lipid and phospholipid fractions of tumour lipids in animals fed Maxepa (P<0.01 at least). This was accompanied by reduction of linoleic acid and arachidonic acid in these tissues (P<0.01 at least) but was most marked in the metabolically labile phospholipid fraction. There was high mitotic activity in the tumours from all the groups but there was no difference according to diet.
Colorectal cancer is now the second commonest cause of cancer death in Westernised countries; epidemiological studies strongly point to an association with a high dietary fat intake, particularly of animal origin (Armstrong & Doll, 1975; Nicholson et al., 1988) . The major component of dietary fat is triacylyglcerols containing long-chain fatty acids. That high levels (-20%) of exogenous saturated fatty acids can promote colorectal cancer relative to low levels (-5%) has been shown in a number of experimental studies (Bull et al., 1979; Galloway et al., 1987; Nicholson et al., 1990a; Nigro et al., 1975; Reddy et al., 1977) .
The study of specific fats in the aetiology of colorectal cancer in humans has not been adequately determined given the crude nature of epidemiological dietary data and the difficulty in applying reliable dietary assessment techniques to large populations (Bingham, 1987) . Whilst animal experiments have confirmed the tumour promoting potential of saturated fats, the role of unsaturated fatty acids is somewhat controversial. Some authors have reported that dietary fats of vegetable origin which are rich in linoleic acid (18:2, n-6) have a potent co-carcinogenic effect in experimental colon cancer not only at high dietary levels but also at low levels (Broitman et al., 1977; Lochniskar et al., 1985; Reddy et al., 1985; Sakaguchi et al., 1984; Smedley-Machlean & Nunn, 1941; Wilson & Lindsey, 1965) ; others have not (Dayton et al., 1977; Nicholson et al., 1990b) .
Nevertheless, that differences may exist between fatty acid classes in terms of cancer promotion suggests specific structural requirements for such a process. Numerous mechanisms have been proposed, including effects on bile acids (Reddy et al., 1985) , direct luminal effects (Friedman et al., 1989) , alterations in lipid peroxidation (Begin & Das, 1986) , perturbations in membrane fluidity (Brasitus et al., 1985) , changes in immune cytotoxicity (Schlager & Ohanian, 1980) and modulation of prostaglandin synthesis (Wickremasinghe, 1988) .
Although fatty acids can be synthesised from glucose in cancer cells (Kanan et al., 1980) , this is reduced in the presence of an adequate exogenous supply (McGee & Spector, 1975) . In cancer there is reduced re-esterification of free fatty acids in both experimental models (Ooktens et al., 1986) and in patients (Legaspi et al., 1987) ; this could result in increased peripheral utilisation of dietary fatty acids not only by the host tissues but by the cancer tissue. This therefore implies that certain exogenous fatty acids could be used as pharmacological agents and such a role has been proposed for the n-3 series of fatty acids (Begin & Das, 1986 ). Thus, three recent studies have shown reduced colon carcinogenesis in azoxymethane treated rodents given dietary n-3 lipids (Reddy & Maruyama, 1986; Reddy & Sugie, 1988; Minoura et al., 1988) .
In the Maxepa diet contained small amounts of dodecyl gallate and <0.01% (W/W) of cholesterol. The calculated energy value for the standard diet was 11.8MJkg-' and 12.9MJ kg-' for the high fat diets. Both the high fat diets were prepared daily in order to avoid auto-oxidation of highly unsaturated fatty acids. Determination of the fatty acids in these diets was undertaken using chloroformmethanol extraction and analysis of the methyl esters using gas-liquid chromatography (see below). The fatty acid composition of these three diets is shown in Table I .
Assessment of tumour growth Tumour volumes and weight were performed using minor modifications of previously described techniques (Euhus et al., 1986; Fiennes, 1988) . The coefficient of correlation between tumour weight and tumour volume measured by these techniques in two separate experiments was r = 0.945 (n = 13) and r = 0.988 (n = 10), both P < 0.001. Some divergence of the volumetric method from actual weights was noted with very large tumours due to subdermal invasion despite being situated over the rib cage.
Analytical procedures
At death 1.5 ml of blood was drawn into EDTA coated tubes. Red cell membranes were prepared, lipids extracted, saponified and fatty acids derivatised to the methyl esters exactly as previously described (Neoptolemos & Thomas, 1990) . In all analytical procedures, samples were kept on ice and the antioxidant butylated-hydroxytoluene was used.
Adipose tissue and tumour tissue were weighed and then snap frozen and stored in liquid nitrogen. Lipids were extracted from these tissues using a technique previously described (Bligh & Dyer, 1959) . In the case of tumour lipids these were separated into neutral lipid and phospholipid fractions prior to saponification. Briefly, silica Sep-Pak cartridges were primed with methanol and chloroform and loaded with 0.5 ml of the crude total lipid. Addition of 20 ml of chloroform resulted in separation of the neutral lipids followed by the phospholipid fraction with 2 ml of methanol. Complete separation was confirmed by thin layer chromatography (TLC) on silica plates using chloroform:methanol: acetic acid:distilled water (170:15:15:12) and identification with 50% sulphuric acid and charring. Subsequent treatments of these lipids was as described for the red cell membranes. With these methods the extraction of all the major fatty acids from red cells, adipose tissue and tumour tissue was 95-100% with coefficients of variation of <5%.
Fatty acid methyl esters (FAMES) were analysed by gasliquid chromatography (GLC) using a Phillips PU 4400 chromatograph (Cambridge, UK) with a programmable temperature vapouriser (PTV), flame ionisation detector, Phillips PU 6600 data station and computer integrator and automatic injection. An open tube capillary column was used (WCOT Fused Silica, 0.22 mm x 50 M, Chrompak Ltd, Holland) either in the PTV or split mode and 1 fsl sample injection. Ultra-pure gases were used and were further purified prior to entry into the chromatograph using the following filters: Oxyfilter, Moisture Filter and Charcoal Filters x 2 (Chrompack UK, Ltd, Catalogue nos. 7470-7972). The settings were as follows: H2 2.8 bar, air 2.4 bar and helium 1.5 bar (flow rate of 1.6 ml min-'); the injection port temperature was 260°C for the split mode; PTV mode settings were 8 x 10°C initially followed by 33 x 10°C at full ramp rate (24°C s-') with solvent evaporation; the column temperature was 150°C initially for 2 min ramping to 2°C min-' to 200°C and then 5°C min ' to 240°C and held for 15 min; detection temperature was set at 300°C.
Identification of peaks was made by reference to retention times relative to an internal standard (margaric acid, 17:0) on samples and previous analysis using authentic standards. At least two separate runs were made per sample and their values meaned. Quantification was based on integration of clearly separated peaks.
Tumour protein content was determined using the Lowry technique (Lowry et al., 1951) .
Histology
This was undertaken on coded tissue specimens by one histopathologist (M.N.). Mitotic counts were undertaken in 50 high power fields (HPF; x 400 magnification) for each of the different groups. 
Results
The weights of the animals during the course of the experiment are given in Table II and tumour sizes in Table III . The initial reduction in numbers at week 1 was due to nontumour take. Subsequent reduction in numbers was due to poor health from tumour size. Four of eight animals with HT-29 inoculations receiving the coconut diet were sacrificed at 24 days (because of large tumours) but are included as if at 28 days. There were no significant differences between the groups in terms of change of weight. Tumour volumes and weights were significantly smaller in the Maxepa-fed animals compared to control-diet and coconut-fed animals. There were no significant differences between the tumour sizes of the last two groups.
The histology of the COLO-320 tumours revealed anaplastic high grade carcinomas with extensive necrosis. The mean ( ± s.d.) mitotic indices were: coconut group 7.1 ± 3.08 mitoses HPF-', Maxepa group 6.30 ± 3.37 and for the control group 6.42 ± 4.07. The histology of the HT-29 tumours revealed poorly differentiated adenocarcinomas with foci of necrosis. The mitotic indices were: coconut group 6.6 ± 4.4 mitoses HPF-', Maxepa group 5.7 ± 3.6 and for the control group 4.8 ± 3.0. Analysis of co-variance revealed no statistical difference. Histologically there was no distinction to be made according to dietary group.
The fatty acid content of red blood cell membranes and adipose tissue are shown in Tables IV and V respectively. Important features to note are (1) incorporation of 18:2 (n-6) in both types of tissue corresponds to dietary intakes of 18:2 (n-6) in the different groups; (2) in the Maxepa-fed animals there is a greater degree of incorporation of n-3 fatty acids in red cell membranes relative to adipose tissue.
The fatty acid content in tumour neutral lipid and phospholipid fractions are shown in Tables VI and VII respectively. In both tumour types from animals fed Maxepa, only 2:5 (n-3) and 22:6 (n-3) appeared in the neutral lipid fraction whereas 22:5 (n-3) was present in the phospholipid fraction as well. A marked reduction of 18:2 (n-6) was found in both tumour types from animals fed Maxepa compared to tumours from both the other dietary groups.
Discussion
This study has established for the first time that it is possible to restrict the growth of two human colon cancer cell lines in vivo using a diet high in n-3 lipids. Significant reduction in tumour size occurred not only compared to an equivalent saturated fat diet, but also compared to an isocaloric low fat standard diet. Both the Maxepa and coconut diets were well tolerated by the experimental animals given control inoculations. The COLO-320 tumours were also well tolerated by the animals for the duration of the experiment; however, the (7) 0.025±0 (7) 0.074±0.049 (7) (9) growth rate of HT-29 tumours was quite rapid between week 2 and week 4 necessitating early death in 11 out of 35 animals. In our experimental design we chose only to include animals in whom the inoculated cells became firmly established at I week. Although this occurred in only seven of 12 animals in the group inoculated with COLO-320 cells receiving a control diet, we consider this to have been a chance event. In order to improve the possibility of establishing growth, we selected a relatively high number of cells to be inoculated (I x 107). An alternative might be to combine a lower cell number inoculation containing stromal cells (Pritchard et al., 1989) ; in this situation, however, it may be difficult to differentiate stromal cell growth from tumour cell growth. Even so, failure to establish growth still occurs and emphasises the value of using weekly assessment of tumour growth as undertaken in the present study.
Although the three different animal diets were well matched, there were small but potentially important differences between them. Both the high fat diets contained more vitamin E than the standard diet. The requirement for vitamin E (and other anti-oxidants) is dependent upon the dietary level of polyunsaturated fatty acids. A ratio of at least 0.6 (mg of vitamin E per g of polyunsaturated fatty acids) is required to prevent the development of vitamin E deficiency (Harris & Embree, 1963) . On the other hand the presence of vitamin E which is surplus to this requirement may influence tumour growth. In in vitro systems, vitamin E inhibits breast tumour cell cytotoxicity induced by polyunsaturated fatty acids (Begin, 1987) , while in vitro it inhibits chemically induced breast carcinogenesis (Horvarth & Ip, 1983) . Nevertheless, using experimental systems involving breast cancer as a benchmark the levels of vitamin E used in all three diets were unlikely to influence tumour growth (Begin, 1987; Horvarth & Ip, 1983) .
Another difference in the diets was the presence of a small amount of cholesterol in the Maxepa diet. A dietary level of 1% cholesterol may promote chemically-induced colorectal tumours (Broitman et al., 1977; Hiramatsu et al., 1983) or even less when compared to an elemental diet (Cruse et al., 1984) . In the present study, however, the Maxepa diet reduced tumour growth compared to the other two diets.
Ingested fatty acids were utilised for energy production by beta-oxidation, storage in adipose tissue and incorporation into lipid membranes. As anticipated, marked qualitative differences were found in the distribution of fatty acids in adipose tissue and red cell membranes, which were related to the three different types of dietary intake. These effects were less marked in quantitative terms in the adipose tissue which tends to store fatty acids as derived from the diet. Subsequent utilisation will be dependent upon the requirements for (1) energy and (2) incorporation into membranes which will necessitate further metabolism in order to maintain membrane fluidity by balancing the proportion of saturated to unsaturated fatty acids (Popp-Snijders et al., 1986) . The latter will be dependent on the main substrate polyene fatty acids derived from the diet, i.e. 18:2, n-6 or 18:3, n-3 and the preference of delta-6-desaturase for these substrates: 18:3, n-3 > 18:2, n-6, > 18:1, n-9, > 16:1, n-7 (Jeffcoat & James, 1984) . As illustrated in Tables IV and V, such (Tables VI and VII) . The most marked differences were observed in the phospholipid fraction which is the fraction most metabolically labile. In the Maxepa-fed animals both tumour types incorporated large amounts of the main n-3 fatty acids at the expense of 18:2, n-6. Whether this is simply a reflection of substrate availability or a preference for re-esterification of n-3 fatty acids is not certain. In general, the profile of tumour FAMES was more similar to the changes observed in adipose tissue compared to that occurring in the red cell membranes. What is certain is that alteration of dietary fatty acid intake will result in dramatic tumour lipid alterations. These effects may be amplified by tumour-derived lipolytic factors (Kitada et al., 1981; Beck & Tisdale, 1987) which will tend to release fatty acids from the labile fatty acid pools of adipose tissue which have been recently deposited there from the diet.
Reduction in experimental colon-cancer has recently been demonstrated in rodent models receiving azoxymethane using either fish-oil supplements (Reddy & Maruyam, 1986; Reddy & Sugie, 1988) or eicosapentaenoic acid (20:5, n-3) as the ethyl ester (Minoura et al., 1988) . Changes in tumour lipid composition were observed similar to those reported in the current model (Reddy & Sugie, 1988; Minoura et al., 1988) .
A previous transplanted tumour model did not demonstrate any tumour growth reduction despite apparently similar alterations in tumour lipids in animals fed fish oil (Fady et al., 1988) . There may be several reasons for this: (1) an unusual model has been used, i.e. the rat DHD PROb colon cell line transplated into BDIX synergenic rats; (2) the n-3 diet contained only 9% fish oil which contained only 18% n-3 fatty acids; (3) only 6.8% of the fish oil diet contained 20:5, n-3; (4) tumour lipid incorporation consisted of 7.8% 20:5, n-3 and 17.3% 22:6, n-3. This compares with a total of 30.3% n-3 fatty acids in phospholipid fraction of COLO-320 tumours fed Maxepa and 36.4% similarly in the HT-29 tumours; moreover, the 20:5, n-3 content was 9.9% and 17.8% respectively. This would suggest that in the present study almost complete saturation by n-3 fatty acids of the sn-2 position of tumour phospholipids had occurred. It would appear that both a high n-3 dietary content is required (20%), and that a high proportion of this shouid be 20:5, n-3 for effective tumour growth suppression.
Mitotic index analysis of both tumours surprisingly did not reveal any significant changes by diet. The mitotic activity was very high in both tumour types corresponding to the generally high growth rates. This would imply that the effect of n-3 fatty acids is to contribute to tumour cell destruction rather than to impede cellular division. The mechanism of action of fish oil remains to be elucidated. Possibilities include inhibition of cyclo-oxygenase systems (Culp et al., 1979; Corey et al., 1983) and increased lipid peroxidation (Begin & Das, 1986; Begin & Ells, 1987; Begin et al., 1986 Begin et al., , 1988 Cheeseman et al., 1986) . Moreover, in investigating these mechanisms it will be necessary to determine whether the effects are due to a specific n-3 fatty acid and conversely whether similar effects are obtained with n-6 fatty acids.
